Pazopanib: a novel treatment option for aggressive fibromatosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1186/s13569-016-0061-3.pdf
Reference14 articles.
1. Alman BA, Pajerski ME, Diaz-Cano S, Corboy K, Wolfe HJ. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol. 1997;6(2):98–101.
2. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G, Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer. 2004;100(3):612–20.
3. Heinrich MC, McArthur GA, Demetri GD, Joensuu H, Bono P, Herrmann R, Hirte H, Cresta S, Koslin DB, Corless CL, Dirnhofer S, van Oosterom AT, Nikolova Z, Dimitrijevic S, Fletcher JA. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol. 2006;24(7):1195–203.
4. Penel N, Le Cesne A, Bui BN, Perol D, Brain EG, Ray-Coquard I, Guillemet C, Chevreau C, Cupissol D, Chabaud S, Jimenez M, Duffaud F, Piperno-Neumann S, Mignot L, Blay JY. Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol. 2011;22(2):452–7.
5. Martin-Liberal J, Benson C, McCarty H, Thway K, Messiou C, Judson I. Pazopanib is an active treatment in desmoid tumor/aggressive fibromatosis. Clin Sarcoma Res. 2013;3(1):13.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Management of Soft Tissue Sarcoma;Soft Tissue Sarcoma and Leiomyoma - Diagnosis, Management, and New Perspectives;2024-05-17
2. Evaluation of diagnostic algorithm and therapeutic interventions for intra-abdominal desmoid tumors;Surgical Oncology;2022-05
3. Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis;British Journal of Cancer;2021-03-15
4. Clinical features and long‐term outcomes of aggressive fibromatosis of the abdominal wall after surgical resection: A retrospective study and literature review;Asia-Pacific Journal of Clinical Oncology;2021-02-25
5. The Role of Systemic Therapies in the Management of Soft Tissue Sarcoma;Sarcoma;2020-12-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3